Status:
COMPLETED
EZ-blocker Versus Left Sided Double Lumen Tube in Adult Patients for Thoracic Surgery
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Thoracic Injuries
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The objective of this study is to evaluate the positional stability and quality of lung isolation provided by the EZ-blocker compared to a DLT for both right and left sided thoracic surgery. An addit...
Detailed Description
One lung ventilation (OLV) is frequently used in thoracic surgery to promote surgical exposure and improve operative conditions. At this time, there are two different approaches to OLV in routine use ...
Eligibility Criteria
Inclusion
- Patients greater than 18 and 80 years of age scheduled for thoracoscopic surgery or thoracotomy requiring lung isolation
- Patient presenting as an outpatient for elective thoracic surgery
- In patients scheduled for thoracic surgery.
Exclusion
- History of difficult airway/intubation
- Patients suspected to have a difficult airway.
- Morbid obesity BMI \>39
- Pregnancy
- Emergency status of surgery
- Thoracic surgery requiring a right sided double lumen tube
Key Trial Info
Start Date :
January 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 29 2019
Estimated Enrollment :
163 Patients enrolled
Trial Details
Trial ID
NCT03403192
Start Date
January 26 2018
End Date
October 29 2019
Last Update
October 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest Baptist Hospital
Winston-Salem, North Carolina, United States, 27157